Neuropace, Inc. Common Stock

NPCE Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of NPCE by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
NPCE Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NPCE Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NPCE Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in NPCE holdings by institutional investors

Insider Trading

Quarterly net insider trading by NPCE's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

NPCE Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
Revenue Breakdown

NPCE Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NPCE Income Statement
NPCE Balance Sheet
NPCE Cash Flow
U.S. Patents

New NPCE patent grants

  • Patent Title: Methods and systems for automatically identifying detection parameters for an implantable medical device May. 01, 2018
  • Patent Title: Differential neurostimulation therapy driven by physiological therapy Apr. 17, 2018
  • Patent Title: Differential neurostimulation therapy driven by physiological therapy Jan. 30, 2018
  • Patent Title: Anatomically compliant antenna for implantable medical device Dec. 05, 2017
  • Patent Title: Burr hole covers and methods for using same Oct. 17, 2017
  • Patent Title: Optimizing data retrieval from an active implantable medical device Oct. 10, 2017
  • Patent Title: Methods and systems for automatically identifying detection parameters for an implantable medical device Aug. 29, 2017
  • Patent Title: Low frequency neurostimulator for the treatment of neurological disorders Jul. 04, 2017
  • Patent Title: Systems and methods for interacting with an implantable medical device May. 16, 2017
  • Patent Title: Current management system for a stimulation output stage of an implantable neurostimulation system Mar. 28, 2017
  • Patent Title: Systems, methods and devices for a skull/brain interface Mar. 21, 2017
  • Patent Title: Systems, methods and devices for a skull/brain interface Mar. 21, 2017
  • Patent Title: Devices and methods for monitoring physiological information relating to sleep with an implantable device Mar. 21, 2017
  • Patent Title: Measuring current during delivery of voltage regulated stimulation to a patient Mar. 07, 2017
  • Patent Title: Recessed burr hole covers and methods for using the same Feb. 21, 2017
  • Patent Title: Lead fixation device for securing a medical lead in a human patient Jan. 17, 2017
  • Patent Title: Optimizing data retrieval from an active implantable medical device Nov. 01, 2016
  • Patent Title: Current management system for a stimulation output stage of an implantable neurostimulation system Oct. 18, 2016
  • Patent Title: Methods and systems for controlling a state of a neurostimulator Oct. 11, 2016
  • Patent Title: Differential neurostimulation therapy driven by physiological therapy Sep. 27, 2016
  • Patent Title: Systems, methods and devices for a skull/brain interface Sep. 13, 2016
  • Patent Title: Measuring current during delivery of voltage regulated stimulation to a patient Aug. 30, 2016
  • Patent Title: System and method for optimizing energy use and delivered current in an implantable device Aug. 23, 2016
  • Patent Title: Implantable system enabling responsive therapy for pain Aug. 23, 2016
  • Patent Title: Methods and systems for automatically identifying detection parameters for an implantable medical device Jul. 19, 2016
  • Patent Title: Systems, methods and devices for a skull/brain interface Jul. 12, 2016
  • Patent Title: Systems, methods and devices for a skull/brain interface Jun. 28, 2016
  • Patent Title: Low frequency neurostimulator for the treatment of neurological disorders May. 31, 2016
  • Patent Title: Methods and systems for controlling a state of a neurostimulator May. 24, 2016
  • Patent Title: Devices and methods for monitoring physiological information relating to sleep with an implantable device May. 03, 2016
  • Patent Title: Spatiotemporal pattern recognition for neurological event detection and prediction in an implantable device Apr. 19, 2016
  • Patent Title: Modulation and analysis of cerebral perfusion in epilepsy and other neurological disorders Apr. 05, 2016
  • Patent Title: Systems, methods and devices for a skull/brain interface Mar. 22, 2016
  • Patent Title: Treatment of language, behavior and social disorders Feb. 23, 2016
  • Patent Title: Treatment of language, behavior and social disorders Feb. 23, 2016
  • Patent Title: Optimizing data retrieval from an active implantable medical device Jan. 19, 2016
  • Patent Title: Establishing secure communication between an implantable medical device and an external device Jan. 12, 2016
  • Patent Title: Systems and methods for interacting with an implantable medical device Jan. 12, 2016
  • Patent Title: Systems, devices, and methods for monitoring and analyzing research animal behavior before, during and after brain electrical stimulation Jan. 05, 2016
  • Patent Title: Responsive electrical stimulation for movement disorders Nov. 17, 2015
  • Patent Title: Spatiotemporal pattern recognition for neurological event detection and prediction in an implantable device Nov. 17, 2015
  • Patent Title: Systems, methods and devices for a skull/brain interface Nov. 10, 2015
  • Patent Title: Systems, methods and devices for a skull/brain interface Oct. 27, 2015
  • Patent Title: Systems, methods and devices for a skull/brain interface Oct. 27, 2015
  • Patent Title: Systems, methods and devices for a skull/brain interface Oct. 27, 2015
  • Patent Title: Treatment of language, behavior and social disorders Oct. 20, 2015
  • Patent Title: Treatment of language, behavior and social disorders Oct. 20, 2015
  • Patent Title: Reinforced sensing and stimulation leads and use in detection systems Oct. 20, 2015
  • Patent Title: Neurostimulator assembly Mar. 15, 2011
  • Patent Title: Neurostimulator assembly Oct. 05, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to NPCE from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
NPCE News

Recent insights relating to NPCE

CNBC Recommendations

Recent picks made for NPCE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NPCE

NPCE Analyst Ratings

NPCE Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NPCE Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NPCE stock a Buy, Sell, or Hold?

  • What is the price target for $NPCE stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NPCE Top Shareholders
Shareholder
Shares Held
NPCE Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NPCE stock?

  • Who owns the most shares of $NPCE stock?

  • What funds own $NPCE stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NPCE Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NPCE Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NPCE

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

  • Address Mountain View, CA
  • Market Cap 478.0 million
  • Employees 209
  • Industrial Classification Surgical & Medical Instruments & Apparatus
Back To Top